rs797044818
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PP3_ModeratePP5_Moderate
The NM_020533.3(MCOLN1):c.1406A>G(p.Asn469Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,613,584 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. N469N) has been classified as Likely benign.
Frequency
Consequence
NM_020533.3 missense
Scores
Clinical Significance
Conservation
Publications
- mucolipidosis type IVInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, ClinGen, G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Lisch epithelial corneal dystrophyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152160Hom.: 0 Cov.: 33 show subpopulations
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461424Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 727018 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152160Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74324 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Mucolipidosis type IV Pathogenic:2Other:1
- -
Variant summary: MCOLN1 c.1406A>G (p.Asn469Ser, legacy name: g.9107A>G) results in a conservative amino acid change located in the polycystin cation channel, PKD1/PKD2 domain (IPR013122) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. Several computational tools predict a significant impact on normal splicing: Three predict the variant creates a cryptic exonic 3' acceptor site, which if used, would result in an in-frame deletion expected to disrupt the pore architecture of the channel (e.g. Zhang_2017). However, these predictions have yet to be confirmed by functional studies. The variant was absent in 250910 control chromosomes (gnomAD). c.1406A>G has been reported in the literature as a biallelic genotype in at least two individuals affected with Mucolipidosis Type 4 (e.g. Sun_2000). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two submitters, including a reputable database, GeneReviews, have provided clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Base pair transition creates a new preferred splice acceptor site that results in a frameshift. Causes atypical MLIV, in which affected persons walk independently and have better communicative skills. -
MCOLN1-related disorder Pathogenic:1
The MCOLN1 c.1406A>G variant is predicted to result in the amino acid substitution p.Asn469Ser. Based on available splicing prediction software, this variant is predicted to result in the creation of an alternate splice acceptor site, truncating the protein (Alamut Visual Plus v1.6.1; SpliceAI); however, prediction programs are imperfect and we cannot be certain of the biological impact of this particular variant. This variant has been reported in homozygous state as well as together with MCOLN1 nonsense variant, in at least two individuals with mucolipidosis IV (described as g.9107A>G, families 48 and 53, Sun et al. 2000. PubMed ID: 11030752; patients 15 and 23, Altarescu et al. 2002. PubMed ID: 12182165; same two patients in both publications). This variant has not been reported in a large population database, indicating this variant is rare. A different missense change impacting the same amino acid (p.Asn469Asp) has also been reported in an individual with mucolipidosis IV (Table 1: ID 4, Misko et al. 2022. PubMed ID: 35425852). The c.1406A>G (p.Asn469Ser) variant is interpreted as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at